Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies.

Fahmy AM, El-Setouhy DA, Ibrahim AB, Habib BA, Tayel SA, Bayoumi NA.

Drug Deliv. 2018 Nov;25(1):12-22. doi: 10.1080/10717544.2017.1410262.

2.

RNAi-mediated resistance to whitefly (Bemisia tabaci) in genetically engineered lettuce (Lactuca sativa).

Ibrahim AB, Monteiro TR, Cabral GB, Aragão FJL.

Transgenic Res. 2017 Oct;26(5):613-624. doi: 10.1007/s11248-017-0035-0. Epub 2017 Jul 15.

PMID:
28712067
4.

Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study.

Yardley DA, Reeves J, Dees EC, Osborne C, Paul D, Ademuyiwa F, Soliman H, Guthrie T, Andersen J, Krekow L, Choksi J, Daniel B, Danso M, Favret A, Oommen S, Brufsky A, Bromund JL, Lin Y, Ibrahim AB, Richards PD.

Clin Breast Cancer. 2016 Dec;16(6):471-479.e1. doi: 10.1016/j.clbc.2016.07.005. Epub 2016 Jul 29.

5.

Intranasal haloperidol-loaded miniemulsions for brain targeting: Evaluation of locomotor suppression and in-vivo biodistribution.

El-Setouhy DA, Ibrahim AB, Amin MM, Khowessah OM, Elzanfaly ES.

Eur J Pharm Sci. 2016 Sep 20;92:244-54. doi: 10.1016/j.ejps.2016.05.002. Epub 2016 May 3.

PMID:
27154259
6.

BIOASSAY-GUIDED FRACTIONATION AND ANTIHYPERTENSIVE PROPERTIES OF FRACTIONS AND CRUDE EXTRACTS OF PERISTROPHE BICALYCULATA (RETZ) NEES.

Abdulazeez MA, Ibrahim S, Ameh DA, Ayo JO, Carvalho LJ, Manosroi J, Ibrahim AB.

Acta Pol Pharm. 2015 Mar-Apr;72(2):319-28. Erratum in: Acta Pol Pharm. 2015 Jul-Aug;72(4):818. Ameh, Danladi Amodu [corrected to Ameh, Danladi A].

7.

RNAi-mediated resistance to viruses in genetically engineered plants.

Ibrahim AB, Aragão FJ.

Methods Mol Biol. 2015;1287:81-92. doi: 10.1007/978-1-4939-2453-0_5.

PMID:
25740357
8.

Modulatory effects of L-carnitine on tamoxifen toxicity and oncolytic activity: in vivo study.

Ibrahim AB, Mansour HH, Shouman SA, Eissa AA, Abu El Nour SM.

Hum Exp Toxicol. 2014 Sep;33(9):968-79. doi: 10.1177/0960327113506237. Epub 2013 Dec 17.

PMID:
24347302
9.

Effect of Er substitution on ultrasonic anomaly in Dy(0.5-x)Er(x)Ba(0.5)CoO3 cobaltates.

Shamsuddin S, Ibrahim AB, Yahya AK.

Ultrasonics. 2013 Aug;53(6):1084-8. doi: 10.1016/j.ultras.2013.02.002. Epub 2013 Feb 17.

PMID:
23497912
10.

Genetic engineering in Cowpea (Vigna unguiculata): history, status and prospects.

Citadin CT, Ibrahim AB, Aragão FJ.

GM Crops. 2011 Jun-Dec;2(3):144-9. doi: 10.4161/gmcr.2.3.18069. Epub 2011 Jun 1. Review.

PMID:
22179190
11.

Pretransplant variables associated with quality of life in liver transplant recipients.

Saab S, Ibrahim AB, Surti B, Durazo F, Han S, Yersiz H, Farmer DG, Ghobrial RM, Goldstein LI, Tong MJ, Busuttil RW.

Liver Int. 2008 Sep;28(8):1087-94. doi: 10.1111/j.1478-3231.2008.01831.x. Epub 2008 Jul 25.

PMID:
18662279
12.

Employment and quality of life in liver transplant recipients.

Saab S, Wiese C, Ibrahim AB, Peralta L, Durazo F, Han S, Yersiz H, Farmer DG, Ghobrial RM, Goldstein LI, Tong MJ, Busuttil RW.

Liver Transpl. 2007 Sep;13(9):1330-8.

13.

Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C.

Saab S, Oh MK, Ibrahim AB, Durazo F, Han S, Yersiz H, Farmer DG, Ghobrial RM, Goldstein LI, Tong MJ, Busuttil RW.

Liver Transpl. 2007 Jul;13(7):1032-8.

14.

The MELD score in advanced liver disease: association with clinical portal hypertension and mortality.

Saab S, Landaverde C, Ibrahim AB, Durazo F, Han S, Yersiz H, Farmer DG, Ghobrial RM, Goldstein LI, Tong MJ, Busuttil RW.

Exp Clin Transplant. 2006 Jun;4(1):395-9.

15.

MELD fails to measure quality of life in liver transplant candidates.

Saab S, Ibrahim AB, Shpaner A, Younossi ZM, Lee C, Durazo F, Han S, Esrason K, Wu V, Hiatt J, Farmer DG, Ghobrial RM, Holt C, Yersiz H, Goldstein LI, Tong MJ, Busuttil RW.

Liver Transpl. 2005 Feb;11(2):218-23.

16.

Seroepidemiology of hepatitis A in patients with chronic liver disease.

Saab S, Lee C, Shpaner A, Ibrahim AB.

J Viral Hepat. 2005 Jan;12(1):101-5.

PMID:
15655056
17.

Same day outpatient transjugular liver biopsies in haemophilia.

Saab S, Cho D, Quon DV, Ibrahim AB, Dong P, Marder V, Logan L.

Haemophilia. 2004 Nov;10(6):727-31.

PMID:
15569168
18.

Hepatitis C positive grafts may be used in orthotopic liver transplantation: a matched analysis.

Saab S, Ghobrial RM, Ibrahim AB, Kunder G, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Busuttil RW.

Am J Transplant. 2003 Sep;3(9):1167-72.

19.

MELD score predicts 1-year patient survival post-orthotopic liver transplantation.

Saab S, Wang V, Ibrahim AB, Durazo F, Han S, Farmer DG, Yersiz H, Morrisey M, Goldstein LI, Ghobrial RM, Busuttil RW.

Liver Transpl. 2003 May;9(5):473-6.

20.

Discordance between ALT values and fibrosis in liver transplant recipients treated with ribavirin for recurrent hepatitis C.

Saab S, Hu R, Ibrahim AB, Goldstein LI, Kunder G, Durazo F, Han S, Yersiz H, Ghobrial RM, Farmer DG, Busuttil RW, Lassman C.

Am J Transplant. 2003 Mar;3(3):328-33.

21.

Unusual characteristics of peritoneal macrophages from aged autoimmune-prone mice.

Ibrahim AB, Stobo JD, Levy JA.

Cell Immunol. 1982 Sep 1;72(1):28-39. No abstract available.

PMID:
6983388
22.

Dietary fat affects immune response, production of antiviral factors, and immune complex disease in NZB/NZW mice.

Levy JA, Ibrahim AB, Shirai T, Ohta K, Nagasawa R, Yoshida H, Estes J, Gardner M.

Proc Natl Acad Sci U S A. 1982 Mar;79(6):1974-8.

23.

Specific immunotherapy proposed for hepatitis B virus infection.

Vyas GN, Schmid R, Ibrahim AB, Rao KR.

Dev Biol Stand. 1975;30:350-6.

PMID:
1204970
24.

Immune response to hepatitis B surface antigen.

Ibrahim AB, Vyas GN, Perkins HA.

Infect Immun. 1975 Jan;11(1):137-41.

25.

Tolerance to hepatitis B antigen: a hypothesis for its termination with 'immune-RNA'.

Vyas GN, Ibrahim AB, Rao KR, Schmid R.

Life Sci. 1974 Jul 15;15(2):261-6. No abstract available.

PMID:
4549917
26.

Studies on delayed hypersensitivity to hepatitis B antigen in chimpanzees.

Ibrahim AB, Vyas GN, Prince AM.

Clin Exp Immunol. 1974 Jun;17(2):311-8. No abstract available.

27.

In vitro transfer of cell-mediated immunity to hepatitis B antigen with RNA.

Vyas GN, Ibrahim AB, Rao KR, Likhite V.

Nature. 1974 Feb 8;247(5440):377-8. No abstract available.

PMID:
4817858
28.

Induction of tolerance to coccidioidin in newborn guinea pigs.

Ibrahim AB.

J Immunol. 1974 Jan;112(1):387-91. No abstract available.

PMID:
4812177
29.

A simple inexpensive method for demonstrating in vitro leukocyte migration.

Ibrahim AB, Vyas GN.

Vox Sang. 1973 Dec;25(6):552-6. No abstract available.

PMID:
4798392
30.

Selective induction of anergy to coccidioidin or tuberculin with antilymphocyte serum.

Ibrahim AB.

Trans N Y Acad Sci. 1973 Nov;35(7):593-8. No abstract available.

PMID:
4518582
31.
32.

Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds.

Vyas GN, Rao KR, Ibrahim AB.

Science. 1972 Dec 22;178(4067):1300-1.

PMID:
4118259
33.

Medical ecology and epidemiology.

Muul I, Liat LB, Ibrahim AB.

Med J Malaya. 1972 Dec;27(2):125-8. No abstract available.

PMID:
4268038
34.

Nicotine effects on alveolar macrophage respiration and adenosine triphosphatase activity.

Meyer DH, Cross CE, Ibrahim AB, Mustafa MG.

Arch Environ Health. 1971 Mar;22(3):362-5. No abstract available.

PMID:
4250713
35.

Choriocarcinoma in a postmenopausal nulligravida.

Bazinet R, Ibrahim AB, Campbell JS.

Can Med Assoc J. 1970 Jan 31;102(2):150-1. No abstract available.

36.

Pulmonary alveolar macrophage: demonstration of Na+ - K+, Mg++ ATPase activity.

Mustafa MG, Ibrahim AB, Le CT, Cross CE.

Life Sci. 1969 Dec 15;8(24):1343-51. No abstract available.

PMID:
4243582

Supplemental Content

Loading ...
Support Center